FDA Issues Revised Draft Guidance on Addressing Misinformation About Prescription Drugs and Medical Devices

This revised draft guidance would apply only to approved/cleared medical products, which include medical devices for human use (including biological products), prescription human drugs (including biological products), and prescription animal drugs.

Leave a Comment

Your email address will not be published. Required fields are marked *